Insmed (INSM) Current Assets (2010 - 2026)
Insmed's (INSM) quarterly Current Assets came in at $1.6 billion in Q1 2026, up 15.01% year-on-year from $1.4 billion in Q1 2025, and down 10.09% quarter-over-quarter from $1.8 billion in Q4 2025.
Insmed (INSM) Current Assets (2010 - 2026) Analysis & Trends
Insmed's Current Assets history runs 17 years deep, the most recent figure standing at $1.6 billion for Q1 2026.
- On a quarterly basis, Current Assets rose 15.01% year-over-year to $1.6 billion in Q1 2026; TTM through Mar 2026 was $1.6 billion, a 15.01% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 10.64% from the prior year.
- Current Assets retreated to $1.6 billion in Q1 2026 per INSM's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Current Assets topped out at $2.1 billion in Q2 2025 and bottomed at $632.2 million in Q3 2022.
- The 5-year median for Current Assets is $1.3 billion (2022), against an average of $1.3 billion.
- Across the five-year window, Current Assets slumped 35.01% in 2022 and jumped 84.88% in 2025, its largest moves.
- Year by year, Current Assets stood at $1.3 billion in 2022, then dropped by 27.04% to $929.1 million in 2023, then jumped by 74.55% to $1.6 billion in 2024, then climbed by 10.64% to $1.8 billion in 2025, then fell by 10.09% to $1.6 billion in 2026.
- Per Business Quant, the three latest INSM Current Assets figures stand at $1.6 billion (Q1 2026), $1.8 billion (Q4 2025), and $1.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | 1.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.61 Bn |
| Dec 31, 2025 | 1.79 Bn |
| Sep 30, 2025 | 1.93 Bn |
| Jun 30, 2025 | 2.08 Bn |
| Mar 31, 2025 | 1.40 Bn |
| Dec 31, 2024 | 1.62 Bn |
| Sep 30, 2024 | 1.65 Bn |
| Jun 30, 2024 | 1.42 Bn |
| Mar 31, 2024 | 758.72 Mn |
| Dec 31, 2023 | 929.06 Mn |
| Sep 30, 2023 | 926.58 Mn |
| Jun 30, 2023 | 1.05 Bn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.27 Bn |
| Sep 30, 2022 | 632.17 Mn |
| Jun 30, 2022 | 674.73 Mn |
| Mar 31, 2022 | 756.14 Mn |
| Dec 31, 2021 | 837.04 Mn |
| Sep 30, 2021 | 958.98 Mn |
| Jun 30, 2021 | 1.04 Bn |